Despite the decrease in VDAC1 and VDAC2 mRNA, we observed that mOGT did not affect the levels of VDAC1 and VDAC2 proteins in the mitochondria of normal and breast cancer cells. This evidence concerns the gene VDAC2 and breast cancer.